Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Ozagrel (sodium) | 189224-26-8 | 99.8% | 1 ML
SDP

Supplier:  Medchemexpress LLC HYB0428A10MM/1ML

Encompass_Preferred

Ozagrel sodium is a highly selective and orally active thromboxane A2 (TXA2) synthase inhibitor with an IC50 of 11 nM. It exerts anti-platelet aggregation, vasodilation, and anti-inflammatory effects by inhibiting the production of TXA2 and increasing the production of prostacyclin (PGI2).

  • Highly selective and orally active
  • Inhibits thromboxane A2 (TXA2) synthase
  • Exerts anti-platelet aggregation effects
  • Promotes vasodilation
  • Possesses anti-inflammatory properties
  • Increases prostacyclin (PGI2) production
  • Suitable for research on ischemic stroke, asthma, and thromboembolic diseases

Catalog No. 50-004-09167


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.